Literature DB >> 16787268

Nonsynaptic receptors for GABA and glutamate.

E Sylvester Vizi1, Arpad Mike.   

Abstract

The concept of nonsynaptic communication between neurons, once a heretic idea, has become a self-evident fact during the almost forty years since its original discovery. In this review we investigate whether the archetypical synaptic transmitters of the central nervous system, Glu and GABA, can operate via nonsynaptic transmission. While experimental data supporting the general concept of nonsynaptic transmission has been progressively accumulating during these years, most of the evidence regarding nonsynaptic transmission by Glu and GABA are results of the last decade. In this paper we collect evidence for different forms of nonsynaptic transmission by the Gluergic and GABAergic system. We investigate two theoretical predictions of the concept of nonsynaptic transmission in the light of recent progress in the field: i) since extrasynaptic receptors experience a lower concentration of agonist, they are likely to have higher affinity for the agonist ii) extrasynaptic receptors are expected to be more important pharmacological targets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787268     DOI: 10.2174/156802606777323782

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  10 in total

1.  Atorvastatin and Fluoxetine Prevent Oxidative Stress and Mitochondrial Dysfunction Evoked by Glutamate Toxicity in Hippocampal Slices.

Authors:  Fabiana K Ludka; Tharine Dal-Cim; Luisa Bandeira Binder; Leandra Celso Constantino; Caio Massari; Carla I Tasca
Journal:  Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.590

Review 2.  Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment.

Authors:  E S Vizi; A Fekete; R Karoly; A Mike
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

Review 3.  Extrasynaptic GABAA receptors in the crosshairs of hormones and ethanol.

Authors:  Istvan Mody
Journal:  Neurochem Int       Date:  2007-07-17       Impact factor: 3.921

4.  Sequential changes in AMPA receptor targeting in the developing neocortical excitatory circuit.

Authors:  Julia Brill; John R Huguenard
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

5.  Posteromedial cortex glutamate and GABA predict intrinsic functional connectivity of the default mode network.

Authors:  Dimitrios Kapogiannis; David A Reiter; Auriel A Willette; Mark P Mattson
Journal:  Neuroimage       Date:  2012-09-18       Impact factor: 6.556

Review 6.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

7.  Involvement of the sigma1 (sigma1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41.

Authors:  J Espallergues; P Lapalud; A Christopoulos; V A Avlani; P M Sexton; A Vamvakides; T Maurice
Journal:  Br J Pharmacol       Date:  2007-08-06       Impact factor: 8.739

8.  Medial Septal NMDA Glutamate Receptors are Involved in Modulation of Blood Natural Killer Cell Activity in Rats.

Authors:  Magdalena Podlacha; Wojciech Glac; Magdalena Listowska; Beata Grembecka; Irena Majkutewicz; Dorota Myślińska; Karolina Plucińska; Grażyna Jerzemowska; Maria Grzybowska; Danuta Wrona
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-10       Impact factor: 4.147

Review 9.  A new meaning for "Gin & Tonic": tonic inhibition as the target for ethanol action in the brain.

Authors:  Istvan Mody; Joseph Glykys; Weizheng Wei
Journal:  Alcohol       Date:  2007-05-23       Impact factor: 2.405

Review 10.  Integration and regulation of glomerular inhibition in the cerebellar granular layer circuit.

Authors:  Lisa Mapelli; Sergio Solinas; Egidio D'Angelo
Journal:  Front Cell Neurosci       Date:  2014-02-25       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.